Insulin resistance is the basis of both non‐alcoholic fatty liver disease (NAFLD) and
metabolic syndrome (MetS), the two conditions are often found in the same individual. The …

Non‐alcoholic fatty liver disease (NAFLD) describes a spectrum of liver conditions from
simple steatosis, steatohepatitis to end‐stage liver disease. The prevalence of NAFLD has …

The top three leading causes of death in patients with nonalcoholic fatty liver disease
(NAFLD) in descending order are cardiovascular disease, cancer, and liver disease. It is …

Non alcoholic fatty liver disease (NAFLD) is defined as fat accumulation exceeding 5% to
10% by the weight of the liver, in the absence of other causes of steatosis. NAFLD is strongly …

Nonalcoholic fatty liver disease (NAFLD) is a common disease that is usually accompanied
by insulin resistance (IR). Whether or how NAFLD and IR are temporally and mechanistically …

Non-alcoholic fatty liver disease (NAFLD) is a common disorder in the Western hemisphere.
It encompasses two histological lesions: fatty liver and steatohepatitis. A large body of …

Because of the global obesity epidemic, the incidence and prevalence of nonalcoholic fatty
liver disease (NAFLD) have increased worldwide, including among Koreans. Recently, the …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are two
diseases that are common in the general population. To date, many studies have been …

Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for advanced liver
disease, type 2 diabetes (T2DM), and cardiovascular diseases. The prevalence of NAFLD in …

Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver
diseases worldwide, causing considerable liver-related mortality and morbidity. Over the last …